MEDIGEN VACCINE BIOLOGICS CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52 TWD | -0.95% |
|
+3.59% | -25.82% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Medigen Vaccine Biologics Corporation is a Taiwan-based company principally engaged in the development and manufacturing of vaccines and biological agents. The Company is engaged in the development of cutting edge technologies for cell-based human vaccines production. For vaccine development, the Company has established the manufacturing process for H1N1 and H5N1. Further, it also conducts clinical trials to confirm safety and efficacy of produced vaccines. In addition, the Company is also engaged in biological agents business.
Sector
Pharmaceuticals
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -25.82% | 528M | |
| -4.56% | 87.31B | |
| +2.63% | 40.86B | |
| -21.76% | 29.36B | |
| +58.56% | 24.49B | |
| -14.78% | 17.31B | |
| -18.49% | 11.62B | |
| -15.61% | 11.31B | |
| -44.02% | 11.26B | |
| +5.17% | 8.31B |
- Stock Market
- Equities
- 6547 Stock
- News Medigen Vaccine Biologics Corporation
- Medigen Vaccine Biologics : 'Made in Taiwan' COVID-19 vaccines could be ready in July, says minister
